April 30 (Reuters) - Genocea Biosciences Inc GNCA.O :
* GENOCEA BIOSCIENCES INC - EXPECT GEN-009 PHASE 1/2A PART B
READOUT IN Q3
* GENOCEA BIOSCIENCES INC - CLINICAL STAGE PROGRAMS GEN-009
AND
GEN-011 CONTINUE TO ADVANCE ANTICIPATE GEN-011 IND FILING IN Q2
* GENOCEA BIOSCIENCES INC - GEN-011 VIRTUAL SYMPOSIUM
PLANNED FOR
MAY 12TH
* GENOCEA BIOSCIENCES- EXPECTS THAT ITS EXISTING CASH AND
CASH
EQUIVALENTS ARE SUFFICIENT TO SUPPORT ITS OPERATIONS INTO THE Q1
OF 2021
Source text for Eikon: ID:nGNX1NPWBc
Further company coverage: GNCA.O
((Reuters.Briefs@thomsonreuters.com;))